- Home
- CPIX vs CALC Comparison
CPIX vs CALC Comparison
Compare CPIX & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- CALC
- Stock Information
- Founded
- CPIX 1999
- CALC 2011
- Country
- CPIX United States
- CALC United States
- Employees
- CPIX N/A
- CALC N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- CALC Health Care
- Exchange
- CPIX Nasdaq
- CALC Nasdaq
- Market Cap
- CPIX 37.9M
- CALC 40.3M
- IPO Year
- CPIX 2009
- CALC N/A
- Fundamental
- Price
- CPIX $2.53
- CALC $3.09
- Analyst Decision
- CPIX
- CALC Strong Buy
- Analyst Count
- CPIX 0
- CALC 5
- Target Price
- CPIX N/A
- CALC $18.20
- AVG Volume (30 Days)
- CPIX 509.3K
- CALC 26.8K
- Earning Date
- CPIX 03-04-2025
- CALC 11-13-2024
- Dividend Yield
- CPIX N/A
- CALC N/A
- EPS Growth
- CPIX N/A
- CALC N/A
- EPS
- CPIX N/A
- CALC N/A
- Revenue
- CPIX $36,785,442.00
- CALC N/A
- Revenue This Year
- CPIX N/A
- CALC N/A
- Revenue Next Year
- CPIX N/A
- CALC N/A
- P/E Ratio
- CPIX N/A
- CALC N/A
- Revenue Growth
- CPIX N/A
- CALC N/A
- 52 Week Low
- CPIX $1.04
- CALC $2.05
- 52 Week High
- CPIX $3.93
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- CPIX 59.45
- CALC 50.07
- Support Level
- CPIX $2.21
- CALC $2.73
- Resistance Level
- CPIX $3.93
- CALC $3.28
- Average True Range (ATR)
- CPIX 0.33
- CALC 0.29
- MACD
- CPIX -0.00
- CALC 0.02
- Stochastic Oscillator
- CPIX 20.00
- CALC 42.00
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.